These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8444754)

  • 1. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
    Wilens TE; Biederman J; Spencer T; Geist DE
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nortriptyline in the treatment of ADHD: a chart review of 58 cases.
    Wilens TE; Biederman J; Geist DE; Steingard R; Spencer T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):343-9. PubMed ID: 8444763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
    Biederman J; Baldessarini RJ; Goldblatt A; Lapey KA; Doyle A; Hesslein PS
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):805-13. PubMed ID: 8340302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
    Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
    J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
    Costedoat-Chalumeau N; Amoura Z; Lupoglazoff JM; Huong DL; Denjoy I; Vauthier D; Sebbouh D; Fain O; Georgin-Lavialle S; Ghillani P; Musset L; Wechsler B; Duhaut P; Piette JC
    Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
    Wilens TE; Biederman J; Baldessarini RJ; Geller B; Schleifer D; Spencer TJ; Birmaher B; Goldblatt A
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1491-501. PubMed ID: 8936916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
    Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic medication in children and the QT interval: case report and discussion.
    Alderton HR
    Can J Psychiatry; 1995 Aug; 40(6):325-9. PubMed ID: 7585402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.
    Prince JB; Wilens TE; Biederman J; Spencer TJ; Millstein R; Polisner DA; Bostic JQ
    J Child Adolesc Psychopharmacol; 2000; 10(3):193-204. PubMed ID: 11052409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Wilens T; Steingard R; Geist D
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder.
    Geller B; Cooper TB; Graham DL; Fetner HH; Marsteller FA; Wells JM
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):34-44. PubMed ID: 1537779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.
    Wilens TE; Biederman J; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):45-8. PubMed ID: 9000780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untoward effects of lithium treatment in children aged four through six years.
    Hagino OR; Weller EB; Weller RA; Washing D; Fristad MA; Kontras SB
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1584-90. PubMed ID: 8543529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.